Cytokinetics (CYTK) Appoints Robert E. Landry to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Cytokinetics (CYTK) Appoints Robert E. Landry to its Board

Cytokinetics Names Robert E. Landry to Board of Directors

February 11, 2025 7:30 AM EST

Appointment Deepens Financial and Operational Expertise of Board
as Company Approaches Potential Commercialization

SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of Robert E. Landry to its Board of Directors. Mr. Landry brings over three decades of financial and operational expertise in the pharmaceutical industry, most recently having served as the Chief Financial Officer at Regeneron Pharmaceuticals Inc. for 11 years.

We are pleased to have Bob join our Board as we approach a key... More